BioMarin Pharmaceuticals, Inc. (BMRN) Tops Q3 EPS by 14c
Tweet
Share
E-mailGet Alerts BMRN Hot Sheet
Price: $68.53 -2.43%
Financial Fact:
Net product revenues: 278.26M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Net product revenues: 278.26M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) reported Q3 EPS of $0.04, $0.14 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $113.4 million versus the consensus estimate of $113.2 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $114 at Canaccord
- MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
- Innovaro (INV) Misses Q2 EPS by 9c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
